FXYD1 and cardiac hypertrophy: Phosphorylation of PLM at Ser63/Ser68 underpins the inhibition of its activity towards the sodium pump and its hypophosphorylation at these two sites has been implicated to play a role in the development of cardiac hypertrophy [6].